229 related articles for article (PubMed ID: 27798262)
1. Autoimmune manifestations in aged mice arise from early-life immune dysregulation.
Mahmoud TI; Wang J; Karnell JL; Wang Q; Wang S; Naiman B; Gross P; Brohawn PZ; Morehouse C; Aoyama J; Wasserfall C; Carter L; Atkinson MA; Serreze DV; Braley-Mullen H; Mustelin T; Kolbeck R; Herbst R; Ettinger R
Sci Transl Med; 2016 Oct; 8(361):361ra137. PubMed ID: 27798262
[TBL] [Abstract][Full Text] [Related]
2. NOD.H-2h4 mice: an important and underutilized animal model of autoimmune thyroiditis and Sjogren's syndrome.
Braley-Mullen H; Yu S
Adv Immunol; 2015; 126():1-43. PubMed ID: 25727287
[TBL] [Abstract][Full Text] [Related]
3. Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndrome.
Karnell JL; Mahmoud TI; Herbst R; Ettinger R
Mol Immunol; 2014 Dec; 62(2):277-82. PubMed ID: 24907930
[TBL] [Abstract][Full Text] [Related]
4. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
Voynova E; Lefebvre F; Qadri A; Muller S
J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
6. Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice.
Ellis JS; Wan X; Braley-Mullen H
Immunology; 2013 Jun; 139(2):179-86. PubMed ID: 23293979
[TBL] [Abstract][Full Text] [Related]
7. Injection of CD40 DNA vaccine ameliorates the autoimmune pathology of non-obese diabetic mice with Sjögren's syndrome.
Zhou YB; Yuan X; Wang QK; Zhang H; Wang GS; Li XP; Wang Y; Harris D; Li XM
Immunol Lett; 2020 Oct; 226():62-70. PubMed ID: 32707129
[TBL] [Abstract][Full Text] [Related]
8. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
9. Non-proliferating plasma cells detected in the salivary glands and bone marrow of autoimmune NOD.B10.H2b mice, a model for primary Sjögren's syndrome.
Szyszko EA; Aqrawi LA; Jonsson R; Brokstad KA; Skarstein K
Autoimmunity; 2016; 49(1):41-9. PubMed ID: 26324998
[TBL] [Abstract][Full Text] [Related]
10. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome.
Wieczorek G; Bigaud M; Pfister S; Ceci M; McMichael K; Afatsawo C; Hamburger M; Texier C; Henry M; Cojean C; Erard M; Mamber N; Rush JS
Ann Rheum Dis; 2019 Jul; 78(7):974-978. PubMed ID: 30902822
[TBL] [Abstract][Full Text] [Related]
11. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.
Nguyen CQ; Gao JH; Kim H; Saban DR; Cornelius JG; Peck AB
J Immunol; 2007 Jul; 179(1):382-90. PubMed ID: 17579059
[TBL] [Abstract][Full Text] [Related]
12. Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome.
Puñet-Ortiz J; Sáez Moya M; Cuenca M; Caleiras E; Lazaro A; Engel P
Front Immunol; 2018; 9():2661. PubMed ID: 30519241
[TBL] [Abstract][Full Text] [Related]
13. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
14. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model.
Humphreys-Beher MG; Peck AB
Arch Oral Biol; 1999 May; 44 Suppl 1():S21-5. PubMed ID: 10414851
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune B Cell Repertoire in a Mouse Model of Sjögren's Syndrome.
Sáez Moya M; Gutiérrez-Cózar R; Puñet-Ortiz J; Rodríguez de la Concepción ML; Blanco J; Carrillo J; Engel P
Front Immunol; 2021; 12():666545. PubMed ID: 33968069
[TBL] [Abstract][Full Text] [Related]
16. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
[TBL] [Abstract][Full Text] [Related]
17. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
18. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome.
Robinson CP; Brayer J; Yamachika S; Esch TR; Peck AB; Stewart CA; Peen E; Jonsson R; Humphreys-Beher MG
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7538-43. PubMed ID: 9636185
[TBL] [Abstract][Full Text] [Related]
19. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
20. Toll-Like Receptor 7 Is Required for Lacrimal Gland Autoimmunity and Type 1 Diabetes Development in Male Nonobese Diabetic Mice.
Debreceni IL; Chimenti MS; Serreze DV; Geurts AM; Chen YG; Lieberman SM
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
